Literature DB >> 33947472

Exploring the heterogeneity of factors that may influence implementation of PrEP in family planning clinics: a latent profile analysis.

Kaitlin N Piper1, Regine Haardörfer2, Cam Escoffery2, Anandi N Sheth3, Jessica Sales2.   

Abstract

BACKGROUND: Title X-funded family planning clinics have been identified as optimal sites for delivery of pre-exposure prophylaxis (PrEP) for HIV prevention. However, PrEP has not been widely integrated into family planning services, especially in the Southern US, and data suggest there may be significant implementation challenges in this setting. Because Title X clinics vary greatly in provider-, organizational-, and systems-level characteristics, there is likely variation in capacity to implement PrEP across clinics.
METHODS: We conducted a survey from February to June 2018 among providers and administrators of non-PrEP-providing Title X-funded clinics across 18 southern states. Survey items were designed using the Consolidated Framework for Implementation Research (CFIR) to assess constructs relevant to PrEP implementation. To explore the heterogeneity of CFIR-related implementation determinants and identify distinct sub-groups of Title X clinics, a latent profile analysis was conducted using nine CFIR constructs: complexity, relative advantage, cost, attitudes, implementation climate, compatibility, leadership engagement, available resources, and cosmopolitanism. We then conducted a multi-level analysis (accounting for nesting of participants within clinics) to test whether group membership was associated with readiness for implementation of PrEP, controlling for key sociodemographic characteristics.
RESULTS: Four hundred and fourteen healthcare providers/administrators from 227 non-PrEP-providing Title X clinics participated in the study. We identified six sub-groups of clinics that each had distinct patterns of PrEP implementation determinants. Clinic sub-groups included "Highest Capacity for Implementation", "Favorable Conditions for Implementation", "Mixed Implementation Context", "Neutral Implementation Context", "Incompatible Setting for Implementation", and "Resource-Strained Setting". Group membership was related to numerous provider-level (i.e., ability to prescribe medication) and clinic-level (i.e., provision of primary care) characteristics. In comparison to the "Neutral" group (which held neutral perceptions across the implementation determinants), the "Highest Capacity" and "Favorable Conditions" groups had significantly higher levels of implementation readiness, and the "Resource-Strained" group had a significantly lower level of implementation readiness.
CONCLUSIONS: Latent profile analyses can help researchers understand how implementation readiness varies across healthcare settings, promoting tailoring of implementation strategies to unique contexts.

Entities:  

Keywords:  Consolidated Framework for Implementation Research; Family planning; HIV/AIDS; Implementation science; Latent profile analysis; PrEP

Year:  2021        PMID: 33947472     DOI: 10.1186/s43058-021-00148-3

Source DB:  PubMed          Journal:  Implement Sci Commun        ISSN: 2662-2211


  18 in total

1.  United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.

Authors:  Dominika Seidman; Kimberly Carlson; Shannon Weber; Jacki Witt; Patricia J Kelly
Journal:  Contraception       Date:  2016-01-06       Impact factor: 3.375

2.  Ending the HIV Epidemic: A Plan for the United States.

Authors:  Anthony S Fauci; Robert R Redfield; George Sigounas; Michael D Weahkee; Brett P Giroir
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

3.  Patient recommendations for PrEP information dissemination at family planning clinics in Atlanta, Georgia.

Authors:  Jessica M Sales; Ashley L Phillips; Ilyssa Tamler; Tatiana Munoz; Carrie Cwiak; Anandi N Sheth
Journal:  Contraception       Date:  2019-01-31       Impact factor: 3.375

4.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Authors:  Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-06-15       Impact factor: 3.797

5.  Geographic Access to Preexposure Prophylaxis Clinics Among Men Who Have Sex With Men in the United States.

Authors:  Aaron J Siegler; Anna Bratcher; Kevin M Weiss
Journal:  Am J Public Health       Date:  2019-07-18       Impact factor: 9.308

6.  Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.

Authors:  Judith D Auerbach; Suzanne Kinsky; Gina Brown; Vignetta Charles
Journal:  AIDS Patient Care STDS       Date:  2014-12-16       Impact factor: 5.078

7.  Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.

Authors:  Patrick S Sullivan; Robertino Mera Giler; Farah Mouhanna; Elizabeth S Pembleton; Jodie L Guest; Jeb Jones; Amanda D Castel; Howa Yeung; Michael Kramer; Scott McCallister; Aaron J Siegler
Journal:  Ann Epidemiol       Date:  2018-06-22       Impact factor: 3.797

8.  Methods to Improve the Selection and Tailoring of Implementation Strategies.

Authors:  Byron J Powell; Rinad S Beidas; Cara C Lewis; Gregory A Aarons; J Curtis McMillen; Enola K Proctor; David S Mandell
Journal:  J Behav Health Serv Res       Date:  2017-04       Impact factor: 1.505

9.  Women's clinical preventive services in the United States: who is doing what?

Authors:  Analía R Stormo; Mona Saraiya; Esther Hing; Jillian T Henderson; George F Sawaya
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

10.  Health insurance coverage among women of reproductive age before and after implementation of the affordable care act.

Authors:  Rachel K Jones; Adam Sonfield
Journal:  Contraception       Date:  2016-01-21       Impact factor: 3.375

View more
  3 in total

1.  Implementation of an HIV Pre-exposure Prophylaxis Strategy Into Abortion and Early Pregnancy Loss Care.

Authors:  Sarita Sonalkar; Arden McAllister; Corinne Kete; Jessica Fishman; Alhambra Frarey; William R Short; Courtney A Schreiber; Anne Teitelman
Journal:  J Acquir Immune Defic Syndr       Date:  2022-07-01       Impact factor: 3.771

2.  Using the Exploration-Preparation-Implementation-Sustainment (EPIS) Framework to prepare for the implementation of evidence-based practices into adolescent HIV settings.

Authors:  April Idalski Carcone; Karin Coyle; Seyram Butame; Gary W Harper; Gregory A Aarons; Sylvie Naar
Journal:  AIDS Behav       Date:  2022-09-06

3.  Applying implementation science frameworks to identify factors that influence the intention of healthcare providers to offer PrEP care and advocate for PrEP in HIV clinics in Colombia: a cross-sectional study.

Authors:  Jorge Luis Martinez-Cajas; Julian Torres; Hector Fabio Mueses; Pilar Camargo Plazas; Marcela Arrivillaga; Sheila Andrea Gomez; Ximena Galindo; Ernesto Martinez Buitrago; Beatriz Eugenia Alvarado Llano
Journal:  Implement Sci Commun       Date:  2022-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.